Which statement describes the onset and resolution of serotonin syndrome after starting or changing therapy?

Which statement describes the onset and resolution of serotonin syndrome after starting or changing therapy?

• A. Onset within 24 hours of starting or changing medication and resolves within a few days
• B. Onset within weeks and resolves in 1 month
• C. Onset after months and resolves after several months
• D. Onset within hours and resolves within 1 day

Answer: (A)

Serotonin syndrome tends to occur quickly after starting or increasing a serotonergic medication because there’s a rapid surge in central and peripheral serotonin activity. The typical onset is within hours to about 24 hours after the change. If the offending drug is stopped promptly and supportive care is provided, symptoms usually improve within a few days. This rapid course is a key feature that helps distinguish it from other syndromes like neuroleptic malignant syndrome, which tends to develop more gradually over days to weeks and resolves more slowly after withdrawal. The syndrome presents with a triad of autonomic instability, neuromuscular excitability (such as tremor and clonus), and mental status changes, and management focuses on stopping the serotonergic agents, providing supportive care, and using benzodiazepines or, in some cases, a serotonin antagonist like cyproheptadine.

Serotonin syndrome tends to occur quickly after starting or increasing a serotonergic medication because there’s a rapid surge in central and peripheral serotonin activity. The typical onset is within hours to about 24 hours after the change. If the offending drug is stopped promptly and supportive care is provided, symptoms usually improve within a few days. This rapid course is a key feature that helps distinguish it from other syndromes like neuroleptic malignant syndrome, which tends to develop more gradually over days to weeks and resolves more slowly after withdrawal. The syndrome presents with a triad of autonomic instability, neuromuscular excitability (such as tremor and clonus), and mental status changes, and management focuses on stopping the serotonergic agents, providing supportive care, and using benzodiazepines or, in some cases, a serotonin antagonist like cyproheptadine.